X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Panacea Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE PANACEA BIOTECH TTK HEALTHCARE/
PANACEA BIOTECH
 
P/E (TTM) x 52.2 174.3 29.9% View Chart
P/BV x 9.6 3.9 248.2% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 TTK HEALTHCARE   PANACEA BIOTECH
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
PANACEA BIOTECH
Mar-14
TTK HEALTHCARE/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs663149 446.1%   
Low Rs39982 484.8%   
Sales per share (Unadj.) Rs535.684.1 636.6%  
Earnings per share (Unadj.) Rs15.9-18.3 -87.1%  
Cash flow per share (Unadj.) Rs20.0-6.7 -298.9%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs137.683.7 164.4%  
Shares outstanding (eoy) m7.7761.25 12.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.01.4 72.2%   
Avg P/E ratio x33.3-6.3 -528.0%  
P/CF ratio (eoy) x26.5-17.2 -153.8%  
Price / Book Value ratio x3.91.4 279.8%  
Dividend payout %25.10-   
Avg Mkt Cap Rs m4,1277,074 58.3%   
No. of employees `0001.72.8 62.1%   
Total wages/salary Rs m6071,449 41.9%   
Avg. sales/employee Rs Th2,436.71,874.1 130.0%   
Avg. wages/employee Rs Th355.2527.0 67.4%   
Avg. net profit/employee Rs Th72.5-407.7 -17.8%   
INCOME DATA
Net Sales Rs m4,1625,154 80.8%  
Other income Rs m61100 61.3%   
Total revenues Rs m4,2235,254 80.4%   
Gross profit Rs m197-766 -25.7%  
Depreciation Rs m32711 4.5%   
Interest Rs m301,503 2.0%   
Profit before tax Rs m197-2,881 -6.8%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m0-6 0.0%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m7317 433.3%   
Profit after tax Rs m124-1,121 -11.0%  
Gross profit margin %4.7-14.9 -31.9%  
Effective tax rate %37.0-0.6 -6,345.8%   
Net profit margin %3.0-21.8 -13.7%  
BALANCE SHEET DATA
Current assets Rs m1,6293,810 42.7%   
Current liabilities Rs m1,0588,365 12.6%   
Net working cap to sales %13.7-88.4 -15.5%  
Current ratio x1.50.5 338.0%  
Inventory Days Days30156 19.1%  
Debtors Days Days3467 50.0%  
Net fixed assets Rs m55614,480 3.8%   
Share capital Rs m7861 126.8%   
"Free" reserves Rs m878903 97.3%   
Net worth Rs m1,0695,127 20.9%   
Long term debt Rs m1595,832 2.7%   
Total assets Rs m2,39919,433 12.3%  
Interest coverage x7.6-0.9 -826.9%   
Debt to equity ratio x0.11.1 13.0%  
Sales to assets ratio x1.70.3 654.0%   
Return on assets %6.42.0 326.3%  
Return on equity %11.6-21.9 -53.0%  
Return on capital %18.53.6 507.5%  
Exports to sales %0.824.5 3.2%   
Imports to sales %1.410.2 13.8%   
Exports (fob) Rs m331,264 2.6%   
Imports (cif) Rs m58525 11.1%   
Fx inflow Rs m331,539 2.1%   
Fx outflow Rs m63942 6.7%   
Net fx Rs m-30597 -5.1%   
CASH FLOW
From Operations Rs m127599 21.1%  
From Investments Rs m-146-438 33.3%  
From Financial Activity Rs m22-303 -7.2%  
Net Cashflow Rs m3-141 -1.8%  

Share Holding

Indian Promoters % 65.4 74.5 87.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 0.6 616.7%  
FIIs % 5.2 1.3 400.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 23.6 109.3%  
Shareholders   12,723 10,259 124.0%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   AJANTA PHARMA  GLENMARK PHARMA  SHASUN PHARMA  STRIDES SHASUN LTD  J.B.CHEMICALS  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; PSU & Healthcare Stocks Top Losers(09:30 am)

Asian equities are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 1.20% while the Hang Seng is up 0.61%. The Shanghai Composite is trading up by 0.45%.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Feb 20, 2018 09:47 AM

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - GLENMARK PHARMA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS